Home » Topics » BioWorld Science

BioWorld Science
RSS

Zynaxis terminates agreement in principle for sale of chemistry division

Sep. 6, 1996

Baxter to acquire Immuno AG

Sep. 6, 1996

Cellegy issued patent covering novel drug delivery system

Sep. 6, 1996

Memtec and Gelman Sciences sign merger agreement

Sep. 6, 1996

ImmunoTherapeutics obtains option for drug delivery technology

Sep. 6, 1996

Molecular Simulations and Procept enter research collaboration

Sep. 6, 1996

Renewed collaboration for Ribozyme and Pharmacia Biotech

Sep. 6, 1996

Ontogen and Boehringer Ingelheim sign research agreement

Sep. 6, 1996

NS-2389: a potential new antidepressant

Sep. 6, 1996

Reversible MAO inhibitors from Hoechst Marion Roussel

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...